Disorders of mineral metabolism (E83) ICD-10-CM
The E83 code range covers disorders of mineral metabolism with 40 ICD-10-CM diagnosis codes. 31 of them are billable and valid for claim submission in fiscal year 2026, and the category headers group them but cannot themselves be billed.
Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Codes in the E83 Range 40 codes · 31 billable
- E83 Disorders of mineral metabolismNon-billable
- E83.0 Disorders of copper metabolismNon-billable
- E83.00 Disorder of copper metabolism, unspecified
- E83.01 Wilson's disease
- E83.09 Other disorders of copper metabolism
- E83.1 Disorders of iron metabolismNon-billable
- E83.10 Disorder of iron metabolism, unspecified
- E83.11 HemochromatosisNon-billable
- E83.110 Hereditary hemochromatosis
- E83.111 Hemochromatosis due to repeated red blood cell transfusions
- E83.118 Other hemochromatosis
- E83.119 Hemochromatosis, unspecified
- E83.19 Other disorders of iron metabolism
- E83.2 Disorders of zinc metabolism
- E83.3 Disorders of phosphorus metabolism and phosphatasesNon-billable
- E83.30 Disorder of phosphorus metabolism, unspecified
- E83.31 Familial hypophosphatemia
- E83.32 Hereditary vitamin D-dependent rickets (type 1) (type 2)
- E83.39 Other disorders of phosphorus metabolism
- E83.4 Disorders of magnesium metabolismNon-billable
- E83.40 Disorders of magnesium metabolism, unspecified
- E83.41 Hypermagnesemia
- E83.42 Hypomagnesemia
- E83.49 Other disorders of magnesium metabolism
- E83.5 Disorders of calcium metabolismNon-billable
- E83.50 Unspecified disorder of calcium metabolism
- E83.51 Hypocalcemia
- E83.52 Hypercalcemia
- E83.59 Other disorders of calcium metabolism
- E83.8 Other disorders of mineral metabolismNon-billable
- E83.81 Hungry bone syndrome
- E83.82 Disorders of pyrophosphate metabolismNon-billable
- E83.820 Generalized arterial calcification of infancy with unspecified genetic causality New
- E83.821 ENPP1 deficiency causing generalized arterial calcification of infancy New
- E83.822 ENPP1 deficiency causing autosomal recessive hypophosphatemic rickets type 2 New
- E83.823 ABCC6 deficiency causing generalized arterial calcification of infancy New
- E83.824 ABCC6 deficiency causing pseudoxanthoma elasticum New
- E83.825 CD73 deficiency causing arterial calcification New
- E83.89 Other disorders of mineral metabolism
- E83.9 Disorder of mineral metabolism, unspecified
Clinical Terms in This Code Range
Definitions from the National Library of Medicine for conditions coded in the E83 range.
Calcinosis
Pathologic deposition of calcium salts in tissues.
Calcinosis Cutis
Pathological deposition of calcium in the skin and subcutaneous tissue. Excessive calcification of the skin may be associated with underlying diseases that cause tissue damage (e.g., EHLERS-DANLOS SYNDROME; PSEUDOXANTHOMA ELASTICUM; ROTHMUND-THOMSON SYNDROME; and WERNER SYNDROME) or that cause abnormal calcium and phosphate metabolism (e.g., CALCIPHYLAXIS; CHRONIC KIDNEY FAILURE; HYPERPARATHYROIDISM; and SARCOIDOSIS).
Calciphylaxis
Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.
CREST Syndrome
A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.
Familial Hypophosphatemic Rickets
A hereditary disorder characterized by HYPOPHOSPHATEMIA; RICKETS; OSTEOMALACIA; renal defects in phosphate reabsorption and vitamin D metabolism; and growth retardation. Autosomal and X-linked dominant and recessive variants have been reported.
Hemochromatosis
A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
Hemochromatosis Protein
A membrane protein and MHC class I antigen. It contains an IMMUNOGLOBULIN C1-SET DOMAIN and interacts with BETA 2-MICROGLOBULIN. It may also regulate the interaction of TRANSFERRIN with the TRANSFERRIN RECEPTOR. Mutations in the HFE gene are associated with cases of FAMILIAL HEMOCHROMATOSIS.
Hemosiderosis
Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.
Hemosiderosis, Pulmonary
Iron deposition within the lung. Primary pulmonary hemosiderosis is characterized by HEMOPTYSIS; IRON-DEFICIENCY ANEMIA, and diffuse pulmonary hemorrhage as seen as transient pulmonary infiltrates on RADIOGRAPHY. Even though large amounts of iron are laid down in the lung, with normal or increased total body iron, anemia occurs because of inability of the erythron to use iron sequestered in pulmonary MACROPHAGES.
Hypercalcemia
Abnormally high level of calcium in the blood.
Hyperphosphatemia
A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
Hypocalcemia
Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)
Hypophosphatasia
A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (From Dorland, 27th ed)
Hypophosphatemia
A condition of an abnormally low level of PHOSPHATES in the blood.
Hypophosphatemia, Familial
An inherited condition of abnormally low serum levels of PHOSPHATES (below 1 mg/liter) which can occur in a number of genetic diseases with defective reabsorption of inorganic phosphorus by the PROXIMAL RENAL TUBULES. This leads to phosphaturia, HYPOPHOSPHATEMIA, and disturbances of cellular and organ functions such as those in X-LINKED HYPOPHOSPHATEMIC RICKETS; OSTEOMALACIA; and FANCONI SYNDROME.
Iron Overload
An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989)
Medullary Sponge Kidney
A non-hereditary KIDNEY disorder characterized by the abnormally dilated (ECTASIA) medullary and inner papillary portions of the collecting ducts. These collecting ducts usually contain CYSTS or DIVERTICULA filled with jelly-like material or small calculi (KIDNEY STONES) leading to infections or obstruction. It should be distinguished from congenital or hereditary POLYCYSTIC KIDNEY DISEASES.
Menkes Kinky Hair Syndrome
An inherited disorder of copper metabolism transmitted as an X-linked trait and characterized by the infantile onset of HYPOTHERMIA, feeding difficulties, hypotonia, SEIZURES, bony deformities, pili torti (twisted hair), and severely impaired intellectual development. Defective copper transport across plasma and endoplasmic reticulum membranes results in copper being unavailable for the synthesis of several copper containing enzymes, including PROTEIN-LYSINE 6-OXIDASE; CERULOPLASMIN; and SUPEROXIDE DISMUTASE. Pathologic changes include defects in arterial elastin, neuronal loss, and gliosis. (From Menkes, Textbook of Child Neurology, 5th ed, p125)
Mononuclear Phagocyte System
Mononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. It includes MACROPHAGES and their precursors; PHAGOCYTES; KUPFFER CELLS; HISTIOCYTES; DENDRITIC CELLS; LANGERHANS CELLS; and MICROGLIA. The term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (From Illustrated Dictionary of Immunology, 2d ed.)
Nephrocalcinosis
A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.
Phosphates
Inorganic salts of phosphoric acid.
Rickets, Hypophosphatemic
A disorder characterized by HYPOPHOSPHATEMIA; RICKETS; OSTEOMALACIA; resulting from lack of phosphate reabsorption by the kidneys and possible defects in vitamin D metabolism.
Tetany
A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This condition is associated with unstable depolarization of axonal membranes, primarily in the peripheral nervous system. Tetany usually results from HYPOCALCEMIA or reduced serum levels of MAGNESIUM that may be associated with HYPERVENTILATION; HYPOPARATHYROIDISM; RICKETS; UREMIA; or other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1490)
Vascular Calcification
Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels is associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.
Williams Syndrome
A disorder caused by hemizygous microdeletion of about 28 genes on chromosome 7q11.23, including the ELASTIN gene. Clinical manifestations include SUPRAVALVULAR AORTIC STENOSIS; MENTAL RETARDATION; elfin facies; impaired visuospatial constructive abilities; and transient HYPERCALCEMIA in infancy. The condition affects both sexes, with onset at birth or in early infancy.
About the E83 Code Range
The ICD-10 code section E83 covers various disorders of mineral metabolism, which include imbalances or defects in how the body processes essential minerals such as copper, iron, zinc, phosphorus, magnesium, and calcium. These codes are used to specify diagnoses related to abnormal mineral levels or mineral-related diseases affecting different organs and body systems.
This section includes specific codes like E83.0 for disorders of copper metabolism, such as Wilson's disease (E83.01), a rare genetic disorder causing copper buildup, and other copper-related liver conditions. For iron-related disorders, codes like E83.11 for hemochromatosis identify hereditary or acquired iron overload, while E83.19 covers other iron metabolism issues such as hemosiderosis. Disorders of zinc metabolism (E83.2) and phosphorus metabolism including familial hypophosphatemia (E83.31) are also detailed. Magnesium imbalances range from E83.40 (unspecified disorder) to hypomagnesemia (E83.42). Calcium metabolism disorders like hypocalcemia (E83.51) and hypercalcemia (E83.52) are included as well. This code group helps health professionals accurately document and track mineral metabolic disorders, assisting in diagnosis, treatment, and research related to these conditions.
Questions About This Page
How many billable codes are in the E83 range?
Of the 40 codes in this range, 31 are billable and valid for claim submission from October 1, 2025 through September 30, 2026. Category header codes group them but cannot be reported on claims.
What does the E83 range classify?
The range classifies disorders of mineral metabolism. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.
Related References
Source: CMS FY 2026 ICD-10-CM Tabular List and order file, effective October 1, 2025 through September 30, 2026.
